DIEP皮瓣乳房重建术后并发症的危险因素
本研究回顾性分析2018至2023年212例患者共250例DIEP皮瓣乳房重建,总体并发症率31.1%,皮瓣丢失率1.9%。肥胖、糖尿病、放疗、多穿支及外侧穿支、缝合静脉吻合与并发症增加相关;年龄、高血压、化疗、重建时机与侧别、静脉数量及术后阿司匹林未影响结局。
要点
- 肥胖和糖尿病与晚期皮瓣并发症及供区并发症显著相关。
- 多穿支较单穿支供区并发症显著增多;外侧穿支早期皮瓣并发症显著增多。
- 吻合器静脉吻合较缝合法皮瓣并发症显著降低。
核心结论
- 肥胖、糖尿病、放疗、使用多穿支及外侧穿支、缝合静脉吻合与并发症增加相关;年龄、高血压、化疗、重建侧别与时机、静脉数量、吻合器尺寸及术后阿司匹林未影响结局。
研究设计与样本
- 回顾性分析2018至2023年212例患者共250例DIEP皮瓣乳房重建的病历资料。
主要发现
- 总体并发症率为31.1%,皮瓣丢失率为1.9%。
- 肥胖和糖尿病与晚期皮瓣并发症及供区并发症(裂开、感染、脂肪坏死和血清肿)显著相关。
- 放疗显示总皮瓣丢失、再手术和皮瓣皮肤坏死增加的趋势。
- 多穿支较单穿支供区并发症显著增多;外侧穿支较内侧穿支早期皮瓣并发症显著增多,并有凸出增多的趋势。
- 吻合器静脉吻合较缝合法皮瓣并发症显著降低。
关键数值与推荐
- 总体并发症率31.1%,皮瓣丢失率1.9%。
- 年龄、高血压、吸烟和化疗与并发症增加无关。
- 重建时机、侧别、静脉数量和术后阿司匹林使用不影响结局。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: This study investigated patient- and surgery-related risk factors of postoperative complications in microvascular breast reconstruction with deep inferior epigastric perforator (DIEP) flaps. METHODS: We reviewed the retrospective charts of 212 patients who underwent 250 DIEP flap breast reconstructions between 2018 and 2023. Patient-related factors included demographic characteristics, comorbidities, radiation therapy, and chemotherapy. Surgery-related factors included reconstructive timing and laterality, perforator choice, venous anastomosis technique, and postoperative acetylsalicylic acid (ASA). Early flap complications (first postoperative week) included flap loss, venous congestion, and hematoma. Late flap complications (after the first postoperative week) included wound dehiscence, skin necrosis, fat necrosis, and infection. Donor-site complications (all late) included wound dehiscence, skin necrosis, infection, seroma, and bulging. RESULTS: The overall complication rate was 31.1%, and flap loss was 1.9%. Obesity and diabetes were significantly associated with late flap complications and donor-site complications (dehiscence, infection, fat necrosis, and seroma). Radiation therapy showed trends toward greater total flap loss, take back, and flap skin necrosis. Age, hypertension, smoking, and chemotherapy were not associated with higher complications. Harvesting multiple versus a single perforator was associated with significantly more donor-site complications. There were significantly more early flap complications and a trend toward more bulging with lateral versus medial row perforators. Venous anastomosis with a coupler versus a suture showed significantly lower flap complications. Reconstruction timing, laterality, vein number, and ASA use did not impact outcomes. CONCLUSION: Complications increased by obesity, diabetes, radiation therapy, and the use of multiple and lateral row perforators, as well as sutured venous anastomoses. Conversely, outcomes were not affected by age, hypertension, chemotherapy, reconstructive laterality and timing, vein number, coupler size, or postoperative ASA use.
引用
- Remy K, Sapino G, Koch N, et al. Postoperative complications in breast reconstruction with deep inferior epigastric perforator flap: Looking for evidence. J Plast Reconstr Aesthet Surg. 2025. PMID: 40188534. doi:10.1016/j.bjps.2025.02.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。